We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Plerith works with high growth start-ups and scaling companies to plan for and deliver growth. The company asserts that it helps companies promote their business to potential funders, through its network of angel and venture capital investors depending on the stage and sector of the said business. Plerith is partnering with Newable and Bristol Private Equity Club to deliver the fund in the South West London (SWL) area and identify and invest in the most exciting high growth companies in the region. Plerith argues that its deep knowledge of fundraising, sales, strategy, finance and technology would help SWL businesses flourish. Plerith aims to provide investors access to the highest quality local companies in the SWL region.
days to go: Stretch investment: Withheld
Yolk, also known as In One Basket Limited, is a pioneering company revolutionizing the food and coffee experience for people on the move. They provide high-quality sandwiches, salads, and improved breakfast options without the premium cost, boasting five successful locations in London and three upcoming openings in the second half of 2023
days to go: TBC investment: Withheld
A sustainable food company intorducing insects as a regular Western food. Eat Grub now has listings at UK and European retailers. Their wide product range includes roasted cricket snacks and protein bars. The company also sells B2B to major pubs and restaurants such as Wahaca and Fat Duck, as well as directly to customers via Amazon. After creating a new website, funds are sought to increase national sales and digital marketing.
days to go: Expired investment: £150,028
A craft brewery from Salford, Manchester specialising in producing beers for those new to drinking the beverage. Seven Bro7hers sell their products through many channels. This includes at retailers such as Booths and Co-Op, restaurants, airports, hotels and train stations. Seven Bro7hers opened their first beer house in December 2016 and quickly moved their business into a new brewery by October 2017. Revenue has increased from £204k to £708k between 2016 and 2017. Since establishing the company in 2014, their brewing capability has increased from 1,600L to 2,340L and their fermenting capacity increased from 5,000L to 32,500L. Investment is sought to open 4 more beer houses, which will become an essential core to the business. These will provide high gross margins with clients through vertical integration.
days to go: Expired investment: £628,700
UNS Homes Ltd is a property renovation company that purchases houses and revitalises their interiors before selling them on at a profit.These guys know that it takes more than a lick of paint and a little elbow grease to make a house a home. By continuing to come up with new ideas, the company stays ahead of the marketplace and creates modern-look interiors. Such innovative thinking has helped the company build a solid track record, having sold every one of its refurbished properties since 2008 when the company was first established. This thinking also contributed to the company almost quadrupling its profits year-on-year in 2013. UNS Home’s current trading figures show a monthly turnover of over £31,000.The renovators recently identified a way in which it can use its extensive knowledge and ties with contractors and suppliers to take advantage of a growing market with huge potential. With the backing of a loan-funded investment, the company wants to make its renovation expertise available to homeowners as a service, providing customers with tailor-made renovations.A loan investment will ensure the company has enough working capital to take on new projects and help them keep growing business. The loan investment will also ensure the company is able to benefit from supplier discounts that are only available with immediate payment.
days to go: Expired investment: £6,950
Nebeus aims to bridge the gap between cryptocurrency and cash, providing people with instant crypto-backed cash services for everyday use. The company argues that there is an equivalent of $400 billion held in more than 55 million crypto wallets around the world which cannot be used further than keeping as an investment. It aims to change this scenario. Nebeus's core product is its 'Instant Loans' offering. It also offers users to do mobile top-ups, conduct Card2Card transfers, and send cash to Points of Sale (PoS) amongst other financial services. The company is working to come out with a 'Nebeus Mastercard' in partnership with Railsbank in Q1 of 2021. Nebeus has more than 60,000 users on its portal and has overseen transactions over £30 million to date. The company has featured in publications like The Independent, Forbes, and Bloomberg to name a few. It will use the investment for growth and marketing, the rollout of Nebeus Mastercard rollout, for growing its team, and for Research and Development (R&D).
days to go: Expired investment: £862,580
Evaclite manufactures dynamic exit signs designed to make buildings safer and save lives. The company argues that its products are 77% more visible than conventional exit signs and reduces congestion at exits by 36%. The company received the 2018 FIREX - Fire Innovation of the Year Award. It also won the Safety and Health Excellence (SHE) Award in 2019 and 2020. Evaclite counts companies like Apple, CBRE, BBC, Melia, and MetroBank amongst its clients. The company has inquiries from over a dozen countries globally with a 12-month sales opportunity pipeline of over £1.5 million. It will use 60% of the investment to build its sales team, 28% to boost its inbound marketing campaign, 7% to develop additional intellectual property, and 5% towards overhead and general costs.

Pitch Rated

81%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £148,736
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph